Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF – Get Free Report) was the recipient of a significant decrease in short interest in July. As of July 15th, there was short interest totaling 8,056 shares, a decrease of 53.5% from the June 30th total of 17,343 shares. Based on an average daily trading volume, of 1,382 shares, the short-interest ratio is currently 5.8 days.
Fisher & Paykel Healthcare Stock Performance
Shares of Fisher & Paykel Healthcare stock remained flat at $22.96 on Tuesday. The company has a 50-day moving average of $22.09 and a 200-day moving average of $22.60. Fisher & Paykel Healthcare has a 52 week low of $19.01 and a 52 week high of $25.69.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.
The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.
See Also
- Five stocks we like better than Fisher & Paykel Healthcare
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
